Charles River Laboratories International Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Charles River Laboratories International ha un patrimonio netto totale di $3.8B e un debito totale di $2.3B, che porta il suo rapporto debito/patrimonio netto a 60.1%. Le sue attività totali e le sue passività totali sono rispettivamente $8.0B e $4.2B. L'EBIT di Charles River Laboratories International è $608.6M rendendo il suo rapporto di copertura degli interessi 4.9. Ha liquidità e investimenti a breve termine pari a $210.2M.
Informazioni chiave
60.1%
Rapporto debito/patrimonio netto
US$2.30b
Debito
| Indice di copertura degli interessi | 4.9x |
| Contanti | US$210.17m |
| Patrimonio netto | US$3.83b |
| Totale passività | US$4.18b |
| Totale attività | US$8.00b |
Aggiornamenti recenti sulla salute finanziaria
Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03Recent updates
Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
Nov 19Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 26What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You
Oct 11Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $1.5B ) di CRL superano le sue passività a breve termine ( $1.0B ).
Passività a lungo termine: Le attività a breve termine di CRL ( $1.5B ) non coprono le sue passività a lungo termine ( $3.2B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 54.6% ) di CRL è considerato alto.
Riduzione del debito: Il rapporto debito/patrimonio netto di CRL si è ridotto da 120.6% a 60.1% negli ultimi 5 anni.
Copertura del debito: Il debito di CRL è ben coperto dal flusso di cassa operativo ( 34.6% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di CRL sono ben coperti dall'EBIT ( 4.9 x copertura).